andrew huberman bpc-157 NEW podcast episode is up! Dr. — Peptides, Performance, and Protocols Andrew Huberman, Ph.D., is a neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University What are the benefits of

Accessed on November 6, 2025 at Reis, G., & Kosmas, C

Unlike many peptides, BPC-157 is stable in gastric juice, allowing oral administration for GI conditions

What Improves Outcomes for Good Candidates Even in ideal candidates, outcomes depend on execution

BPC-157 has demonstrated cytoprotective and wound-healing properties across gastrointestinal, musculoskeletal, and neurological models, acting through VEGF-mediated angiogenesis and nitric oxide system modulation

Weeks 1-4: Foundation period During the initial retatrutide-only phase at 1 mg, expect mild appetite changes and possibly slight weight loss (1-3 lbs)

The chart below lists what to watch for and when to adjust